Weekly nab-paclitaxel plus carboplatin as neoadjuvant therapy for IIIA-N2 lung squamous cell carcinoma: A prospective phase II study.

被引：1
|
作者：
Zhu, Jian-Quan
Zhang, Yu
Yue, Dongsheng
Zhao, Xiaoliang
Zhang, Qiang
Chen, Hui
Wang, Changli
机构：
[1] Tianjin Canc Hosp, Tianjin, Peoples R China
[2] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e20501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20501
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung
    Yang, Jin-Ji
    Huang, Cheng
    Chen, Gong-Yan
    Song, Yong
    Cheng, Ying
    Yan, Hong-Hong
    Zhou, Qing
    Wu, Yi-Long
    BMC CANCER, 2014, 14
  • [22] A phase 2 feasibility study of nab-paclitaxel and carboplatin in epithelial carcinoma of the uterus
    Pothuri, B.
    Sawaged, Z.
    Karpel, H. C.
    Li, X.
    Lee, J.
    Musa, F.
    Lutz, K.
    Reese, E.
    Blank, S. V.
    Boyd, L. R.
    Curtin, J. P.
    Goldberg, J. D.
    Muggia, F. M.
    GYNECOLOGIC ONCOLOGY, 2024, 190 : 209 - 214
  • [23] Efficacy and safety of weekly nab-paclitaxel plus carboplatin advanced non-small cell lung cancer
    Satouchi, Miyako
    Okamoto, Isamu
    Sakai, Hiroshi
    Yamamoto, Nobuyuki
    Ichinose, Yukito
    Ohmatsu, Hironobu
    Nogami, Naoyuki
    Takeda, Koji
    Mitsudomi, Tetsuya
    Kasahara, Kazuo
    Negoro, Shunichi
    LUNG CANCER, 2013, 81 (01) : 97 - 101
  • [24] A phase I/II study of Carboplatin plus Nab-Paclitaxel in PS 2 pts with advanced non-small-cell lung cancer
    Niwa, Takashi
    Nakashima, Kazuhisa
    Yoshioka, Hiroshige
    Iwamoto, Yasuo
    Akamatsu, Hiroaki
    Murakami, Haruyasu
    Mori, Keita
    Takahashi, Toshiaki
    ANNALS OF ONCOLOGY, 2017, 28
  • [25] Biomarker Analyses from a Phase II Trial of Nab-Paclitaxel/Carboplatin vs Emcitabine/Carboplatin in Advanced Squamous Cell Lung Cancer
    Yang, Jin-Ji
    Ben, Xiao-Song
    Huang, Cheng
    Song, Yong
    Cheng, Ying
    Chen, Gongyan
    Yan, Hong-Hong
    Zhou, Qing
    Chen, Hua-Jun
    Zhang, Xu-Chao
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S656 - S656
  • [26] A phase II trial of first-line nab-paclitaxel/carboplatin versus gemcitabine/carboplatin in advanced squamous cell carcinoma of the lung (CTONG1002)
    Yang, Jinji
    Huang, Cheng
    Song, Yong
    Cheng, Ying
    Chen, Gongyan
    Yan, Hong-Hong
    Zhou, Qing
    Chen, Huajun
    Ben, Xiao-song
    Wu, Yi-Long
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [27] Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study
    Joseph, Deepa M.
    Malik, Monica Irukulla
    Jonnadula, Jyothi
    Ahmed, Fayaz
    Valiyaveettil, Deepthi
    SOUTH ASIAN JOURNAL OF CANCER, 2021, 10 (03) : 151 - 154
  • [28] Randomized phase II trial of carboplatin plus nab-paclitaxel versus cisplatin plus gemcitabine for chemotherapy-naive squamous cell carcinoma: North Japan lung cancer study group 1302
    Kawashima, Yosuke
    Harada, Toshiyuki
    Fujita, Yuka
    Nakagawa, Taku
    Watanabe, Kana
    Morikawa, Naoto
    Takamura, Kei
    Kanazawa, Kenya
    Kuda, Tomoya
    Usui, Kazuhiro
    Sekine, Akimasa
    Inoue, Akira
    Sugawara, Shunichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (03) : 515 - 522
  • [29] Weekly nab-paclitaxel followed by FEC in patients with operable breast cancer: Phase II study.
    Seki, Hirohito
    Asamuna, Fumiki
    Morinaga, Shyoujiro
    Suzuki, Keiichi
    Kaneda, Munehisa
    Kamiya, Noriki
    Ishii, Yoshiyuki
    Osaku, Masayoshi
    Ikeda, Tadashi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [30] IMpower131: Primary PFS and safety analysis of a randomized phase III study of atezolizumab plus carboplatin plus paclitaxel or nab-paclitaxel vs carboplatin plus nab-paclitaxel as 1L therapy in advanced squamous NSCLC.
    Jotte, Robert M.
    Cappuzzo, Federico
    Vynnychenko, Ihor
    Stroyakovskiy, Daniil
    Abreu, Delvys Rodriguez
    Hussein, Maen A.
    Soo, Ross A.
    Conter, Henry Jacob
    Kozuki, Toshiyuki
    Silva, Carlos
    Graupner, Vilma
    Sun, Shawn
    Lin, Ray S.
    Kelsch, Claudia
    Kowanetz, Marcin
    Tien Hoang
    Sandler, Alan
    Socinski, Mark A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (18)
12345